Asian Registry of the BioFreedom Stent for STEMI Patients

CompletedOBSERVATIONAL

Enrollment

914

Participants

Timeline

Start Date

November 22, 2018

Primary Completion Date

January 30, 2022

Study Completion Date

August 5, 2022

Conditions

STEMI - ST Elevation Myocardial Infarction

Interventions

DEVICE

PCI

The placement of 1 or more stents in the diseased coronary artery lesion(s).

Trial Locations (5)

Queen Mary Hospital, Hong Kong

Tan Tock Seng Hospital, Singapore

Seoul National University Bundang Hospital, Seoul

Mackay Memorial Hospital, Taipei

Her Majesty Cardiac Centre, Bangkok

All Listed Sponsors

collaborator

Biosensors Interventional Technologies Pte Ltd

UNKNOWN

lead

Biosensors Europe SA

INDUSTRY

NCT03609346 - Asian Registry of the BioFreedom Stent for STEMI Patients | Biotech Hunter | Biotech Hunter